BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 548905 CCn1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C19H21N3O3/c1-3-21-18(23)14-11-20-16-13(9-6-10-15(16)25-2)17(14)22(19(21)24)12-7-4-5-8-12/h6,9-12H,3-5,7-8H2,1-2H3 SHXAYINEIAIQRK-UHFFFAOYSA-N 235278 US9393245, 1::US10085990, Example 1 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 180 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235278&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010869 340095004 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548906 CCn1c(=O)n(-c2ccc(OC)c(OC)c2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C22H21N3O5/c1-5-24-21(26)15-12-23-19-14(7-6-8-17(19)29-3)20(15)25(22(24)27)13-9-10-16(28-2)18(11-13)30-4/h6-12H,5H2,1-4H3 HBWXXRCASVTUIK-UHFFFAOYSA-N 235281 US9393245, 4::US10085990, Example 4 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 14200 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235281&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010870 340095005 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548907 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(C(C)C)c1=O InChI=1S/C20H23N3O3/c1-12(2)22-19(24)15-11-21-17-14(9-6-10-16(17)26-3)18(15)23(20(22)25)13-7-4-5-8-13/h6,9-13H,4-5,7-8H2,1-3H3 USNHXPAJBZXQCY-UHFFFAOYSA-N 235282 US9393245, 5::US10085990, Example 5 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 270 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235282&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762255 340095006 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548908 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccs2)c1=O InChI=1S/C21H19N3O3S/c1-27-16-9-4-8-14-18(16)22-12-15-19(14)23(13-6-2-3-7-13)21(26)24(20(15)25)17-10-5-11-28-17/h4-5,8-13H,2-3,6-7H2,1H3 WEWXZCSTWDNTEE-UHFFFAOYSA-N 235287 US9393245, 10::US10085990, Example 10 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 410 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235287&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010871 340095007 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548909 CCCn1c2c3cccc(OC)c3ncc2c(=O)n(CC)c1=O InChI=1S/C17H19N3O3/c1-4-9-20-15-11-7-6-8-13(23-3)14(11)18-10-12(15)16(21)19(5-2)17(20)22/h6-8,10H,4-5,9H2,1-3H3 UUMJILIRWRRMQI-UHFFFAOYSA-N 235293 US9393245, 16::US10085990, Example 16 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 680 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235293&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010872 340095008 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548910 CCCCn1c2c3cccc(OC)c3ncc2c(=O)n(CC)c1=O InChI=1S/C18H21N3O3/c1-4-6-10-21-16-12-8-7-9-14(24-3)15(12)19-11-13(16)17(22)20(5-2)18(21)23/h7-9,11H,4-6,10H2,1-3H3 MYTFCNPKIZVZPE-UHFFFAOYSA-N 235294 US9393245, 17::US10085990, Example 17 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 390 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235294&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010873 340095009 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548911 CCn1c(=O)n(CC(C)C)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C18H21N3O3/c1-5-20-17(22)13-9-19-15-12(7-6-8-14(15)24-4)16(13)21(18(20)23)10-11(2)3/h6-9,11H,5,10H2,1-4H3 DSQGVLPQTIMWFJ-UHFFFAOYSA-N 235295 US9393245, 18::US10085990, Example 18 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1100 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235295&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010874 340095010 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548912 CCn1c(=O)n(C2CCCC2)c2c3cc(Cl)cc(OC)c3ncc2c1=O InChI=1S/C19H20ClN3O3/c1-3-22-18(24)14-10-21-16-13(8-11(20)9-15(16)26-2)17(14)23(19(22)25)12-6-4-5-7-12/h8-10,12H,3-7H2,1-2H3 SJDNWMAHIOSFDW-UHFFFAOYSA-N 235305 US9393245, 28::US10085990, Example 28 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 3500 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235305 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235305&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010875 340095011 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548913 CCn1c(=O)n(C2CCCC2)c2c3cc(F)cc(OC)c3ncc2c1=O InChI=1S/C19H20FN3O3/c1-3-22-18(24)14-10-21-16-13(8-11(20)9-15(16)26-2)17(14)23(19(22)25)12-6-4-5-7-12/h8-10,12H,3-7H2,1-2H3 JZFDIZGFYOAGNF-UHFFFAOYSA-N 235306 US9393245, 29::US10085990, Example 29 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 920 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235306 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235306&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010876 340095012 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548914 CCn1c(=O)n(C2CCCC2)c2c3cccc(Cl)c3ncc2c1=O InChI=1S/C18H18ClN3O2/c1-2-21-17(23)13-10-20-15-12(8-5-9-14(15)19)16(13)22(18(21)24)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 RNTPXDNXVJTNNP-UHFFFAOYSA-N 135812 US8853226, 30::US9393245, 30::US10085990, Example 30::US9833457, 30::US10568888, Example 30 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2500 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135812&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762338 249493580 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548915 CCCc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(CC)c1=O InChI=1S/C21H25N3O2/c1-3-8-14-9-7-12-16-18(14)22-13-17-19(16)24(15-10-5-6-11-15)21(26)23(4-2)20(17)25/h7,9,12-13,15H,3-6,8,10-11H2,1-2H3 IAIFPELWEXGBKC-UHFFFAOYSA-N 135813 US8853226, 32::US9393245, 32::US10085990, Example 32::US9833457, 32::US10568888, Example 32 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2600 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135813&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762254 249493581 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548916 CCn1c(=O)n(C2CCCC2)c2c3cccc(C(C)C)c3ncc2c1=O InChI=1S/C21H25N3O2/c1-4-23-20(25)17-12-22-18-15(13(2)3)10-7-11-16(18)19(17)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 IWWGJHDCEUWDTE-UHFFFAOYSA-N 135814 US8853226, 33::US9393245, 33::US10085990, Example 33::US9833457, 33::US10568888, Example 33 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 20000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135814&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762293 249493582 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548917 CCn1c(=O)n(C2CCCC2)c2c3cccc(OC(F)(F)F)c3ncc2c1=O InChI=1S/C19H18F3N3O3/c1-2-24-17(26)13-10-23-15-12(8-5-9-14(15)28-19(20,21)22)16(13)25(18(24)27)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 LQKZFQQCAIABHJ-UHFFFAOYSA-N 235308 US9393245, 34::US10085990, Example 34 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 3600 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235308 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235308&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010877 340095013 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548918 CCn1c(=O)n(C(C)C)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C17H19N3O3/c1-5-19-16(21)12-9-18-14-11(7-6-8-13(14)23-4)15(12)20(10(2)3)17(19)22/h6-10H,5H2,1-4H3 OCWUAPKGIXHEQM-UHFFFAOYSA-N 235311 US9393245, 37::US10085990, Example 37 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 20000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235311 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235311&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010878 340095014 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548919 CCC(C)n1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C21H25N3O3/c1-4-13(2)23-20(25)16-12-22-18-15(10-7-11-17(18)27-3)19(16)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 NBFTZVSMVCSLPI-UHFFFAOYSA-N 235312 US9393245, 38::US10085990, Example 38 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 450 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235312 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235312&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010879 340095015 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548920 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccccc2)c1=O InChI=1S/C23H21N3O3/c1-29-19-13-7-12-17-20(19)24-14-18-21(17)25(15-10-5-6-11-15)23(28)26(22(18)27)16-8-3-2-4-9-16/h2-4,7-9,12-15H,5-6,10-11H2,1H3 RSCKXYMEBLRFKV-UHFFFAOYSA-N 235313 US9393245, 39::US10085990, Example 39 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1300 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235313 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235313&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762265 340095016 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548921 CCn1c(=O)n(C2CCCC2)c2c3cccc(C)c3ncc2c1=O InChI=1S/C19H21N3O2/c1-3-21-18(23)15-11-20-16-12(2)7-6-10-14(16)17(15)22(19(21)24)13-8-4-5-9-13/h6-7,10-11,13H,3-5,8-9H2,1-2H3 UPWIYKDVUPWFNE-UHFFFAOYSA-N 235315 US9393245, 41::US10085990, Example 41 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 500 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235315 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235315&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010880 340095017 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548922 CCn1c(=O)n(C2CCC(C)CC2)c2c3cccc(OC)c3ncc2c1=O |(5.33,1.93,;4,2.69,;2.67,1.92,;1.33,2.69,;1.33,4.23,;,1.92,;-1.33,2.69,;-1.33,4.23,;-2.67,5,;-4,4.23,;-5.33,5,;-4,2.69,;-2.67,1.93,;,.38,;-1.33,-.39,;-2.67,.38,;-4,-.39,;-4,-1.93,;-2.67,-2.7,;-2.67,-4.23,;-4,-5,;-1.33,-1.93,;,-2.7,;1.33,-1.93,;1.33,-.39,;2.67,.38,;4,-.39,)| InChI=1S/C21H25N3O3/c1-4-23-20(25)16-12-22-18-15(6-5-7-17(18)27-3)19(16)24(21(23)26)14-10-8-13(2)9-11-14/h5-7,12-14H,4,8-11H2,1-3H3 DLVHYSMNJZZBJZ-UHFFFAOYSA-N 235319 US9393245, 45::US10085990, Example 45 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 200 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235319 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235319&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010881 340095018 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548923 CCOC(=O)Cn1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C21H23N3O5/c1-3-29-17(25)12-23-20(26)15-11-22-18-14(9-6-10-16(18)28-2)19(15)24(21(23)27)13-7-4-5-8-13/h6,9-11,13H,3-5,7-8,12H2,1-2H3 QVFKSVSVSZNHBI-UHFFFAOYSA-N 235320 US9393245, 46::US10085990, Example 46 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235320 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235320&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010882 340095019 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548924 CCn1c(=O)n(CCCF)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C17H18FN3O3/c1-3-20-16(22)12-10-19-14-11(6-4-7-13(14)24-2)15(12)21(17(20)23)9-5-8-18/h4,6-7,10H,3,5,8-9H2,1-2H3 WIXFQAYAKRUUGT-UHFFFAOYSA-N 235321 US9393245, 47::US10085990, Example 47 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 900 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235321 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235321&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010883 340095020 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548925 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(C)c1=O InChI=1S/C18H19N3O3/c1-20-17(22)13-10-19-15-12(8-5-9-14(15)24-2)16(13)21(18(20)23)11-6-3-4-7-11/h5,8-11H,3-4,6-7H2,1-2H3 AIQDEWPLFZXAOT-UHFFFAOYSA-N 235322 US9393245, 48::US10085990, Example 48 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1400 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235322 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235322&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010884 340095021 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548926 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cc(C)cs2)c1=O InChI=1S/C22H21N3O3S/c1-13-10-18(29-12-13)25-21(26)16-11-23-19-15(8-5-9-17(19)28-2)20(16)24(22(25)27)14-6-3-4-7-14/h5,8-12,14H,3-4,6-7H2,1-2H3 XBMCCMKXNQMPDO-UHFFFAOYSA-N 135815 US8853226, 51::US9393245, 51::US10085990, Example 51::US9833457, 51::US10568888, Example 51 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 30.0 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135815&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 91618205 249493583 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548927 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C24H23N3O3/c1-15-7-5-10-17(13-15)27-23(28)19-14-25-21-18(11-6-12-20(21)30-2)22(19)26(24(27)29)16-8-3-4-9-16/h5-7,10-14,16H,3-4,8-9H2,1-2H3 NMCBQDCTQPGXHQ-UHFFFAOYSA-N 135816 US8853226, 54::US9393245, 54::US10085990, Example 54::US9833457, 54::US10568888, Example 54 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 6.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135816&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762299 249493584 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548928 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc(C)cc2)c1=O InChI=1S/C24H23N3O3/c1-15-10-12-17(13-11-15)27-23(28)19-14-25-21-18(8-5-9-20(21)30-2)22(19)26(24(27)29)16-6-3-4-7-16/h5,8-14,16H,3-4,6-7H2,1-2H3 FOCBXVWTIKRGEO-UHFFFAOYSA-N 235327 US9393245, 55::US10085990, Example 55 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 163 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235327 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235327&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762279 340095022 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548929 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2cccc(Cl)c2)c1=O |(-5.33,-5,;-4,-4.23,;-4,-2.69,;-5.33,-1.93,;-5.33,-.38,;-4,.38,;-2.67,-.38,;-2.67,-1.93,;-1.33,-2.69,;,-1.93,;,-.38,;-1.33,.38,;-1.33,1.93,;-2.67,2.69,;-2.67,4.23,;-4,5,;-5.33,4.23,;-6.67,5,;-5.33,2.69,;-4,1.93,;,2.69,;,4.23,;1.33,1.93,;2.67,2.69,;2.67,4.23,;4,5,;5.33,4.23,;5.33,2.69,;6.67,1.93,;4,1.93,;1.33,.38,;2.67,-.38,)| InChI=1S/C25H24ClN3O3/c1-15-9-11-17(12-10-15)28-23-19-7-4-8-21(32-2)22(19)27-14-20(23)24(30)29(25(28)31)18-6-3-5-16(26)13-18/h3-8,13-15,17H,9-12H2,1-2H3 HMHMNSOEZLANDL-UHFFFAOYSA-N 235344 US9393245, 72::US10085990, Example 72 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 4.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235344&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762273 340095023 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548930 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H20ClN3O3/c1-30-19-11-5-10-17-20(19)25-13-18-21(17)26(15-7-2-3-8-15)23(29)27(22(18)28)16-9-4-6-14(24)12-16/h4-6,9-13,15H,2-3,7-8H2,1H3 JUZPJZSDHMNYSS-UHFFFAOYSA-N 235345 US9393245, 73::US10085990, Example 73 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 9.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235345&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762269 340095024 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548931 CCc1cccc(c1)-n1c(=O)n(C2CCCC2)c2c3cccc(OC)c3ncc2c1=O InChI=1S/C25H25N3O3/c1-3-16-8-6-11-18(14-16)28-24(29)20-15-26-22-19(12-7-13-21(22)31-2)23(20)27(25(28)30)17-9-4-5-10-17/h6-8,11-15,17H,3-5,9-10H2,1-2H3 PUVOZFSDIYNDGR-UHFFFAOYSA-N 235347 US9393245, 75::US10085990, Example 75 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 6.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235347&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010885 340095025 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548932 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2cccc(C)c2)c1=O |(-5.33,-5,;-4,-4.23,;-4,-2.69,;-5.33,-1.93,;-5.33,-.38,;-4,.38,;-2.67,-.38,;-2.67,-1.93,;-1.33,-2.69,;,-1.93,;,-.38,;-1.33,.38,;-1.33,1.93,;-2.67,2.69,;-2.67,4.23,;-4,5,;-5.33,4.23,;-6.67,5,;-5.33,2.69,;-4,1.93,;,2.69,;,4.23,;1.33,1.93,;2.67,2.69,;2.67,4.23,;4,5,;5.33,4.23,;5.33,2.69,;6.67,1.93,;4,1.93,;1.33,.38,;2.67,-.38,)| InChI=1S/C26H27N3O3/c1-16-10-12-18(13-11-16)28-24-20-8-5-9-22(32-3)23(20)27-15-21(24)25(30)29(26(28)31)19-7-4-6-17(2)14-19/h4-9,14-16,18H,10-13H2,1-3H3 RUKDKMBIZSFODD-UHFFFAOYSA-N 235350 US9393245, 78::US10085990, Example 78 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235350&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762242 340095026 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548933 CCCCn1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C23H23N3O3/c1-4-5-12-25-21-17-10-7-11-19(29-3)20(17)24-14-18(21)22(27)26(23(25)28)16-9-6-8-15(2)13-16/h6-11,13-14H,4-5,12H2,1-3H3 QEHLDAILVPJKJD-UHFFFAOYSA-N 235355 US9393245, 83::US10085990, Example 83 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235355&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762291 340095027 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548934 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H21N3O5/c1-30-19-8-4-7-16-21(19)25-12-17-22(16)26(14-5-2-3-6-14)24(29)27(23(17)28)15-9-10-18-20(11-15)32-13-31-18/h4,7-12,14H,2-3,5-6,13H2,1H3 JMKXHWHMULJLQG-UHFFFAOYSA-N 135817 US8853226, 84::US9393245, 84::US10085990, Example 84::US9833457, 84::US10568888, Example 84 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135817&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74944884 249493585 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548935 COc1cccc2c1ncc1c2n(C2CCC(F)(F)CC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H20ClF2N3O3/c1-33-19-7-3-6-17-20(19)28-13-18-21(17)29(15-8-10-24(26,27)11-9-15)23(32)30(22(18)31)16-5-2-4-14(25)12-16/h2-7,12-13,15H,8-11H2,1H3 JUOMAZJAWFVNCD-UHFFFAOYSA-N 235358 US9393245, 87::US10085990, Example 87 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235358 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235358&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762290 340095028 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548936 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)OC(C)(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C28H29ClN4O5/c1-28(2,3)38-27(36)31-13-11-18(12-14-31)32-24-20-9-6-10-22(37-4)23(20)30-16-21(24)25(34)33(26(32)35)19-8-5-7-17(29)15-19/h5-10,15-16,18H,11-14H2,1-4H3 WLPGFXATLLKQGT-UHFFFAOYSA-N 235359 US9393245, 88::US10085990, Example 88 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235359&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74944886 340095029 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548937 COc1cccc2c1ncc1c2n(C2CCNCC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C23H21ClN4O3/c1-31-19-7-3-6-17-20(19)26-13-18-21(17)27(15-8-10-25-11-9-15)23(30)28(22(18)29)16-5-2-4-14(24)12-16/h2-7,12-13,15,25H,8-11H2,1H3 CZVSIRAXWOPYTM-UHFFFAOYSA-N 235360 US9393245, 89::US10085990, Example 89 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 5.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235360&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762296 340095030 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548938 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(C)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H23ClN4O4/c1-15(31)28-11-9-17(10-12-28)29-23-19-7-4-8-21(34-2)22(19)27-14-20(23)24(32)30(25(29)33)18-6-3-5-16(26)13-18/h3-8,13-14,17H,9-12H2,1-2H3 LXSZIQSHGAAWFX-UHFFFAOYSA-N 235361 US9393245, 90::US10085990, Example 90 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235361&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762292 340095031 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548939 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)c2ccccc2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C30H25ClN4O4/c1-39-25-12-6-11-23-26(25)32-18-24-27(23)34(30(38)35(29(24)37)22-10-5-9-20(31)17-22)21-13-15-33(16-14-21)28(36)19-7-3-2-4-8-19/h2-12,17-18,21H,13-16H2,1H3 DFTGKUJJDBYDBZ-UHFFFAOYSA-N 235362 US9393245, 91::US10085990, Example 91 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235362&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762238 340095032 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548940 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H23ClN4O5S/c1-34-20-8-4-7-18-21(20)26-14-19-22(18)28(16-9-11-27(12-10-16)35(2,32)33)24(31)29(23(19)30)17-6-3-5-15(25)13-17/h3-8,13-14,16H,9-12H2,1-2H3 MUQKVPSLHRVESB-UHFFFAOYSA-N 135818 US8853226, 92::US9393245, 92::US10085990, Example 92::US9833457, 92::US10568888, Example 92 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2.40 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135818&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74944887 249493586 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548941 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)C(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C26H27ClN4O5S/c1-16(2)37(34,35)29-12-10-18(11-13-29)30-24-20-8-5-9-22(36-3)23(20)28-15-21(24)25(32)31(26(30)33)19-7-4-6-17(27)14-19/h4-9,14-16,18H,10-13H2,1-3H3 XUUYDWPUWOPVDD-UHFFFAOYSA-N 235363 US9393245, 93::US10085990, Example 93 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.400 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235363&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762317 340095033 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548942 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)N(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H26ClN5O5S/c1-28(2)37(34,35)29-12-10-17(11-13-29)30-23-19-8-5-9-21(36-3)22(19)27-15-20(23)24(32)31(25(30)33)18-7-4-6-16(26)14-18/h4-9,14-15,17H,10-13H2,1-3H3 VBDPBRNLIHHGNF-UHFFFAOYSA-N 235364 US9393245, 94::US10085990, Example 94 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.400 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235364&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762277 340095034 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548943 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)c2ccccc2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C29H25ClN4O5S/c1-39-25-12-6-11-23-26(25)31-18-24-27(23)33(29(36)34(28(24)35)21-8-5-7-19(30)17-21)20-13-15-32(16-14-20)40(37,38)22-9-3-2-4-10-22/h2-12,17-18,20H,13-16H2,1H3 ZPBLUEXWDMMUHO-UHFFFAOYSA-N 235365 US9393245, 95::US10085990, Example 95 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235365&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762247 340095035 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548944 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)C2CCS(=O)(=O)C2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C27H27ClN4O7S2/c1-39-23-7-3-6-21-24(23)29-15-22-25(21)31(27(34)32(26(22)33)19-5-2-4-17(28)14-19)18-8-11-30(12-9-18)41(37,38)20-10-13-40(35,36)16-20/h2-7,14-15,18,20H,8-13,16H2,1H3 HYQJMZNWNFLLRO-UHFFFAOYSA-N 235366 US9393245, 96::US10085990, Example 96 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.400 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235366&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74944948 340095036 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548945 CCNC(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C26H26ClN5O4/c1-3-28-25(34)30-12-10-17(11-13-30)31-23-19-8-5-9-21(36-2)22(19)29-15-20(23)24(33)32(26(31)35)18-7-4-6-16(27)14-18/h4-9,14-15,17H,3,10-13H2,1-2H3,(H,28,34) RWLRTFPNLBUMPG-UHFFFAOYSA-N 235367 US9393245, 97::US10085990, Example 97 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.600 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235367&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762305 340095037 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548946 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)NC(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C27H28ClN5O4/c1-16(2)30-26(35)31-12-10-18(11-13-31)32-24-20-8-5-9-22(37-3)23(20)29-15-21(24)25(34)33(27(32)36)19-7-4-6-17(28)14-19/h4-9,14-16,18H,10-13H2,1-3H3,(H,30,35) IEYGNATYSGSBRX-UHFFFAOYSA-N 235368 US9393245, 98::US10085990, Example 98 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.300 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235368&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762267 340095038 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548947 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2ccccc2Cl)c1=O |(-4.67,-5,;-3.33,-4.23,;-3.33,-2.69,;-4.67,-1.93,;-4.67,-.38,;-3.33,.38,;-2,-.38,;-2,-1.93,;-.67,-2.69,;.67,-1.93,;.67,-.38,;-.67,.38,;-.67,1.93,;-2,2.69,;-2,4.23,;-3.33,5,;-4.67,4.23,;-6,5,;-4.67,2.69,;-3.33,1.93,;.67,2.69,;.67,4.23,;2,1.93,;3.33,2.69,;3.33,4.23,;4.67,5,;6,4.23,;6,2.69,;4.67,1.93,;4.67,.38,;2,.38,;3.33,-.38,)| InChI=1S/C25H24ClN3O3/c1-15-10-12-16(13-11-15)28-23-17-6-5-9-21(32-2)22(17)27-14-18(23)24(30)29(25(28)31)20-8-4-3-7-19(20)26/h3-9,14-16H,10-13H2,1-2H3 OIRXJBOZVQMRJB-UHFFFAOYSA-N 235369 US9393245, 99::US10085990, Example 99 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 20.0 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235369&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010886 340095039 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548948 COc1cccc2c1ncc1c2n(C2CCC(C)CC2)c(=O)n(-c2ccc(Cl)cc2)c1=O |(-5.33,-5,;-4,-4.23,;-4,-2.69,;-5.33,-1.93,;-5.33,-.38,;-4,.38,;-2.67,-.38,;-2.67,-1.93,;-1.33,-2.69,;,-1.93,;,-.38,;-1.33,.38,;-1.33,1.93,;-2.67,2.69,;-2.67,4.23,;-4,5,;-5.33,4.23,;-6.67,5,;-5.33,2.69,;-4,1.93,;,2.69,;,4.23,;1.33,1.93,;2.67,2.69,;4,1.93,;5.33,2.69,;5.33,4.23,;6.67,5,;4,5,;2.67,4.23,;1.33,.38,;2.67,-.38,)| InChI=1S/C25H24ClN3O3/c1-15-6-10-17(11-7-15)28-23-19-4-3-5-21(32-2)22(19)27-14-20(23)24(30)29(25(28)31)18-12-8-16(26)9-13-18/h3-5,8-9,12-15,17H,6-7,10-11H2,1-2H3 ZRGJKRMJNFVOLW-UHFFFAOYSA-N 235370 US9393245, 100::US10085990, Example 100 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.900 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235370&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010887 340095040 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548949 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)C(O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r,wU:16.21,(-4.67,-5.78,;-3.33,-5,;-3.33,-3.47,;-4.67,-2.69,;-4.67,-1.15,;-3.33,-.38,;-2,-1.15,;-2,-2.69,;-.67,-3.47,;.67,-2.69,;.67,-1.15,;-.67,-.38,;-.67,1.15,;-2,1.93,;-2,3.47,;-3.33,4.23,;-4.67,3.47,;-4.67,1.93,;-3.33,1.15,;-6,4.23,;-7.34,3.47,;-6,5.78,;.67,1.93,;.67,3.47,;2,1.15,;3.33,1.93,;3.33,3.47,;4.67,4.23,;6,3.47,;6,1.93,;7.34,1.15,;4.67,1.15,;2,-.38,;3.33,-1.15,)| InChI=1S/C25H22ClN3O5/c1-34-20-7-3-6-18-21(20)27-13-19-22(18)28(16-10-8-14(9-11-16)24(31)32)25(33)29(23(19)30)17-5-2-4-15(26)12-17/h2-7,12-14,16H,8-11H2,1H3,(H,31,32) VLSIAPYZDCCBPU-UHFFFAOYSA-N 135819 US8853226, 103::US9393245, 103::US10085990, Example 103::US10568888, Example 103 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135819&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74931538 249493587 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548950 COc1cccc2c1ncc1c2n(C2CCCCC2)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H22ClN3O3/c1-31-20-12-6-11-18-21(20)26-14-19-22(18)27(16-8-3-2-4-9-16)24(30)28(23(19)29)17-10-5-7-15(25)13-17/h5-7,10-14,16H,2-4,8-9H2,1H3 BOWZLOCTDYTWKK-UHFFFAOYSA-N 235374 US9393245, 106::US10085990, Example 106 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 4.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235374&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010888 340095041 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548951 COc1cccc2c1ncc1c2n(C2CCN(CC2)C(=O)OC(C)(C)C)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C29H30N4O7/c1-29(2,3)40-28(36)31-12-10-17(11-13-31)32-25-19-6-5-7-22(37-4)24(19)30-15-20(25)26(34)33(27(32)35)18-8-9-21-23(14-18)39-16-38-21/h5-9,14-15,17H,10-13,16H2,1-4H3 MYNFJASRUQCJTA-UHFFFAOYSA-N 235375 US9393245, 107::US10085990, Example 107 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1.000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235375&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010889 340095042 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548952 COc1cccc2c1ncc1c2n(C2CCNCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H22N4O5/c1-31-19-4-2-3-16-21(19)26-12-17-22(16)27(14-7-9-25-10-8-14)24(30)28(23(17)29)15-5-6-18-20(11-15)33-13-32-18/h2-6,11-12,14,25H,7-10,13H2,1H3 LEKCAWLPDVDUQR-UHFFFAOYSA-N 235376 US9393245, 108::US10085990, Example 108 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 450 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235376 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235376&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010890 340095043 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548953 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C25H24N4O7S/c1-34-20-5-3-4-17-22(20)26-13-18-23(17)28(15-8-10-27(11-9-15)37(2,32)33)25(31)29(24(18)30)16-6-7-19-21(12-16)36-14-35-19/h3-7,12-13,15H,8-11,14H2,1-2H3 UFKSSXQQJYIWAM-UHFFFAOYSA-N 235377 US9393245, 109::US10085990, Example 109 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 8.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235377 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235377&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010891 340095044 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548954 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(c2)C#N)c1=O InChI=1S/C24H20N4O3/c1-31-20-11-5-10-18-21(20)26-14-19-22(18)27(16-7-2-3-8-16)24(30)28(23(19)29)17-9-4-6-15(12-17)13-25/h4-6,9-12,14,16H,2-3,7-8H2,1H3 RQVALWJXDPCRBH-UHFFFAOYSA-N 235378 US9393245, 110::US10085990, Example 110 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 123 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235378 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235378&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74944950 340095045 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548955 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(SC)c2)c1=O InChI=1S/C24H23N3O3S/c1-30-20-12-6-11-18-21(20)25-14-19-22(18)26(15-7-3-4-8-15)24(29)27(23(19)28)16-9-5-10-17(13-16)31-2/h5-6,9-15H,3-4,7-8H2,1-2H3 ZWHJGDGKNAKKAK-UHFFFAOYSA-N 235379 US9393245, 111::US10085990, Example 111 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 74.0 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235379 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235379&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 74944951 340095046 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548956 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(c2)S(C)(=O)=O)c1=O InChI=1S/C24H23N3O5S/c1-32-20-12-6-11-18-21(20)25-14-19-22(18)26(15-7-3-4-8-15)24(29)27(23(19)28)16-9-5-10-17(13-16)33(2,30)31/h5-6,9-15H,3-4,7-8H2,1-2H3 LTRCCXKUSQMIAV-UHFFFAOYSA-N 235380 US9393245, 112::US10085990, Example 112 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 280 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235380&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010892 340095047 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548957 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)C(=O)OC(C)(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C27H27ClN4O5/c1-27(2,3)37-26(35)30-12-11-18(15-30)31-23-19-9-6-10-21(36-4)22(19)29-14-20(23)24(33)32(25(31)34)17-8-5-7-16(28)13-17/h5-10,13-14,18H,11-12,15H2,1-4H3 CTKRVYLHFHYHOK-UHFFFAOYSA-N 235381 US9393245, 113::BDBM287835 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 0.300 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235381&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 134686717 375077316 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548958 COc1cccc2c1ncc1c2n([C@@H]2CCNC2)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C22H19ClN4O3/c1-30-18-7-3-6-16-19(18)25-12-17-20(16)26(15-8-9-24-11-15)22(29)27(21(17)28)14-5-2-4-13(23)10-14/h2-7,10,12,15,24H,8-9,11H2,1H3 PEPXWYFVYAYCEQ-UHFFFAOYSA-N 235382 US9393245, 114::US10085990, Example 114 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 31.0 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235382 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235382&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010893 340095048 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548959 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3 QBTZSDNOQVLDBB-UHFFFAOYSA-N 135820 US8853226, 115::US9393245, 115::US10085990, Example 115::US9833457, 115::US10568888, Example 115 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 29.0 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135820&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 91618206 249493588 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548960 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)C(=O)OC(C)(C)C)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C27H27ClN4O5/c1-27(2,3)37-26(35)30-12-11-18(15-30)31-23-19-9-6-10-21(36-4)22(19)29-14-20(23)24(33)32(25(31)34)17-8-5-7-16(28)13-17/h5-10,13-14,18H,11-12,15H2,1-4H3 CTKRVYLHFHYHOK-UHFFFAOYSA-N 235383 US9393245, 116::US10085990, Example 116 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235383&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010894 340095049 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548961 COc1cccc2c1ncc1c2n([C@H]2CCNC2)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C22H19ClN4O3/c1-30-18-7-3-6-16-19(18)25-12-17-20(16)26(15-8-9-24-11-15)22(29)27(21(17)28)14-5-2-4-13(23)10-14/h2-7,10,12,15,24H,8-9,11H2,1H3 PEPXWYFVYAYCEQ-UHFFFAOYSA-N 235384 US9393245, 117::US10085990, Example 117 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 1000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235384&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 129010895 340095050 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548962 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3 QBTZSDNOQVLDBB-UHFFFAOYSA-N 135821 US8853226, 118::US9393245, 118::US10085990, Example 118::US9833457, 118::US10568888, Example 118 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 29.0 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135821&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 91618207 249493589 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548963 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCCOc3c2)c1=O InChI=1S/C25H23N3O5/c1-31-20-8-4-7-17-22(20)26-14-18-23(17)27(15-5-2-3-6-15)25(30)28(24(18)29)16-9-10-19-21(13-16)33-12-11-32-19/h4,7-10,13-15H,2-3,5-6,11-12H2,1H3 FUOSKBKPXMUPKQ-UHFFFAOYSA-N 235386 US9393245, 120::US10085990, Example 120 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 240 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235386 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235386&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762330 340095051 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548964 COC(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H23ClN4O5/c1-34-20-8-4-7-18-21(20)27-14-19-22(18)29(16-9-11-28(12-10-16)25(33)35-2)24(32)30(23(19)31)17-6-3-5-15(26)13-17/h3-8,13-14,16H,9-12H2,1-2H3 NZIWLTJRFGAVRA-UHFFFAOYSA-N 235388 US9393245, 124::US10085990, Example 124 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 50000 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235388 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235388&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762241 340095052 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548965 COc1cccc2c1ncc1c2n(CC2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(15-16-9-11-28(12-10-16)36(2,33)34)25(32)30(24(20)31)18-6-3-5-17(26)13-18/h3-8,13-14,16H,9-12,15H2,1-2H3 PYZDPPRYPHIHCL-UHFFFAOYSA-N 235390 US9393245, 126::US10085990, Example 126 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 2.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=235390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=235390&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 76762320 340095053 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548966 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)NS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r,wU:16.21,(-4,-5.01,;-2.67,-4.24,;-2.67,-2.7,;-4,-1.93,;-4,-.39,;-2.67,.38,;-1.33,-.39,;-1.33,-1.93,;,-2.7,;1.33,-1.93,;1.33,-.39,;,.38,;,1.92,;-1.33,2.69,;-1.33,4.23,;-2.67,5.01,;-4,4.23,;-4,2.69,;-2.67,1.92,;-5.33,5,;-6.67,4.23,;-8,5,;-7.44,2.9,;-5.9,2.9,;1.33,2.69,;1.33,4.23,;2.67,1.92,;4,2.69,;4,4.23,;5.33,5,;6.67,4.23,;6.67,2.69,;8,1.92,;5.33,1.92,;2.67,.38,;4,-.39,)| InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(17-11-9-16(10-12-17)28-36(2,33)34)25(32)30(24(20)31)18-6-3-5-15(26)13-18/h3-8,13-14,16-17,28H,9-12H2,1-2H3 QMGJUCFLYMBHRX-UHFFFAOYSA-N 135824 US8853226, 127::US9393245, 127::US10085990, Example 127::US9833457, 127::US10568888, Example 127 Lipopolysaccharide-induced tumor necrosis factor-alpha factor Human 6.00 US Patent 10.7270/Q2RV0QRM aid1795748 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49001063&target=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135824&enzyme=Lipopolysaccharide-induced+tumor+necrosis+factor-alpha+factor&column=ki&startPg=0&Increment=50&submit=Search 72279277 249493592 1 MSVPGPYQAATGPSSAPSAPPSYEETVAVNSYYPTPPAPMPGPTTGLVTGPDGKGMNPPSYYTQPAPIPNNNPITVQTVYVQHPITFLDRPIQMCCPSCNKMIVSQLSYNAGALTWLSCGSLCLLGCIAGCCFIPFCVDALQDVDHYCPNCRALLGTYKRL Lipopolysaccharide-induced tumor necrosis factor-alpha factor LITAF_HUMAN Q99732 D3DUG1 G5E9K0 Q05DW0 Q9C0L6 548967 CCn1c(=O)n(C2CCCC2)c2c3cccc(Cl)c3ncc2c1=O InChI=1S/C18H18ClN3O2/c1-2-21-17(23)13-10-20-15-12(8-5-9-14(15)19)16(13)22(18(21)24)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 RNTPXDNXVJTNNP-UHFFFAOYSA-N 135812 US8853226, 30::US9393245, 30::US10085990, Example 30::US9833457, 30::US10568888, Example 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 17000 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135812&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 76762338 249493580 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548968 CCn1c(=O)n(C2CCCC2)c2c3cccc(Cl)c3ncc2c1=O InChI=1S/C18H18ClN3O2/c1-2-21-17(23)13-10-20-15-12(8-5-9-14(15)19)16(13)22(18(21)24)11-6-3-4-7-11/h5,8-11H,2-4,6-7H2,1H3 RNTPXDNXVJTNNP-UHFFFAOYSA-N 135812 US8853226, 30::US9393245, 30::US10085990, Example 30::US9833457, 30::US10568888, Example 30 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 25000 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135812&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 76762338 249493580 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548969 CCCc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(CC)c1=O InChI=1S/C21H25N3O2/c1-3-8-14-9-7-12-16-18(14)22-13-17-19(16)24(15-10-5-6-11-15)21(26)23(4-2)20(17)25/h7,9,12-13,15H,3-6,8,10-11H2,1-2H3 IAIFPELWEXGBKC-UHFFFAOYSA-N 135813 US8853226, 32::US9393245, 32::US10085990, Example 32::US9833457, 32::US10568888, Example 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 25000 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135813&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 76762254 249493581 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548970 CCCc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(CC)c1=O InChI=1S/C21H25N3O2/c1-3-8-14-9-7-12-16-18(14)22-13-17-19(16)24(15-10-5-6-11-15)21(26)23(4-2)20(17)25/h7,9,12-13,15H,3-6,8,10-11H2,1-2H3 IAIFPELWEXGBKC-UHFFFAOYSA-N 135813 US8853226, 32::US9393245, 32::US10085990, Example 32::US9833457, 32::US10568888, Example 32 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 25000 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135813&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 76762254 249493581 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548971 CCn1c(=O)n(C2CCCC2)c2c3cccc(C(C)C)c3ncc2c1=O InChI=1S/C21H25N3O2/c1-4-23-20(25)17-12-22-18-15(13(2)3)10-7-11-16(18)19(17)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 IWWGJHDCEUWDTE-UHFFFAOYSA-N 135814 US8853226, 33::US9393245, 33::US10085990, Example 33::US9833457, 33::US10568888, Example 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 12400 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135814&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 76762293 249493582 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548972 CCn1c(=O)n(C2CCCC2)c2c3cccc(C(C)C)c3ncc2c1=O InChI=1S/C21H25N3O2/c1-4-23-20(25)17-12-22-18-15(13(2)3)10-7-11-16(18)19(17)24(21(23)26)14-8-5-6-9-14/h7,10-14H,4-6,8-9H2,1-3H3 IWWGJHDCEUWDTE-UHFFFAOYSA-N 135814 US8853226, 33::US9393245, 33::US10085990, Example 33::US9833457, 33::US10568888, Example 33 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 25000 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135814&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 76762293 249493582 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548973 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cc(C)cs2)c1=O InChI=1S/C22H21N3O3S/c1-13-10-18(29-12-13)25-21(26)16-11-23-19-15(8-5-9-17(19)28-2)20(16)24(22(25)27)14-6-3-4-7-14/h5,8-12,14H,3-4,6-7H2,1-2H3 XBMCCMKXNQMPDO-UHFFFAOYSA-N 135815 US8853226, 51::US9393245, 51::US10085990, Example 51::US9833457, 51::US10568888, Example 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 126 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135815&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 91618205 249493583 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548974 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cc(C)cs2)c1=O InChI=1S/C22H21N3O3S/c1-13-10-18(29-12-13)25-21(26)16-11-23-19-15(8-5-9-17(19)28-2)20(16)24(22(25)27)14-6-3-4-7-14/h5,8-12,14H,3-4,6-7H2,1-2H3 XBMCCMKXNQMPDO-UHFFFAOYSA-N 135815 US8853226, 51::US9393245, 51::US10085990, Example 51::US9833457, 51::US10568888, Example 51 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 616 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135815&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 91618205 249493583 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548975 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C24H23N3O3/c1-15-7-5-10-17(13-15)27-23(28)19-14-25-21-18(11-6-12-20(21)30-2)22(19)26(24(27)29)16-8-3-4-9-16/h5-7,10-14,16H,3-4,8-9H2,1-2H3 NMCBQDCTQPGXHQ-UHFFFAOYSA-N 135816 US8853226, 54::US9393245, 54::US10085990, Example 54::US9833457, 54::US10568888, Example 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 78.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135816&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 76762299 249493584 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548976 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2cccc(C)c2)c1=O InChI=1S/C24H23N3O3/c1-15-7-5-10-17(13-15)27-23(28)19-14-25-21-18(11-6-12-20(21)30-2)22(19)26(24(27)29)16-8-3-4-9-16/h5-7,10-14,16H,3-4,8-9H2,1-2H3 NMCBQDCTQPGXHQ-UHFFFAOYSA-N 135816 US8853226, 54::US9393245, 54::US10085990, Example 54::US9833457, 54::US10568888, Example 54 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 338 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135816&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 76762299 249493584 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548977 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H21N3O5/c1-30-19-8-4-7-16-21(19)25-12-17-22(16)26(14-5-2-3-6-14)24(29)27(23(17)28)15-9-10-18-20(11-15)32-13-31-18/h4,7-12,14H,2-3,5-6,13H2,1H3 JMKXHWHMULJLQG-UHFFFAOYSA-N 135817 US8853226, 84::US9393245, 84::US10085990, Example 84::US9833457, 84::US10568888, Example 84 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 513 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135817&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 74944884 249493585 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548978 COc1cccc2c1ncc1c2n(C2CCCC2)c(=O)n(-c2ccc3OCOc3c2)c1=O InChI=1S/C24H21N3O5/c1-30-19-8-4-7-16-21(19)25-12-17-22(16)26(14-5-2-3-6-14)24(29)27(23(17)28)15-9-10-18-20(11-15)32-13-31-18/h4,7-12,14H,2-3,5-6,13H2,1H3 JMKXHWHMULJLQG-UHFFFAOYSA-N 135817 US8853226, 84::US9393245, 84::US10085990, Example 84::US9833457, 84::US10568888, Example 84 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 827 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135817&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 74944884 249493585 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548979 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H23ClN4O5S/c1-34-20-8-4-7-18-21(20)26-14-19-22(18)28(16-9-11-27(12-10-16)35(2,32)33)24(31)29(23(19)30)17-6-3-5-15(25)13-17/h3-8,13-14,16H,9-12H2,1-2H3 MUQKVPSLHRVESB-UHFFFAOYSA-N 135818 US8853226, 92::US9393245, 92::US10085990, Example 92::US9833457, 92::US10568888, Example 92 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 68.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135818&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 74944887 249493586 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548980 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C24H23ClN4O5S/c1-34-20-8-4-7-18-21(20)26-14-19-22(18)28(16-9-11-27(12-10-16)35(2,32)33)24(31)29(23(19)30)17-6-3-5-15(25)13-17/h3-8,13-14,16H,9-12H2,1-2H3 MUQKVPSLHRVESB-UHFFFAOYSA-N 135818 US8853226, 92::US9393245, 92::US10085990, Example 92::US9833457, 92::US10568888, Example 92 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 151 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135818&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 74944887 249493586 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548981 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)C(O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r,wU:16.21,(-4.67,-5.78,;-3.33,-5,;-3.33,-3.47,;-4.67,-2.69,;-4.67,-1.15,;-3.33,-.38,;-2,-1.15,;-2,-2.69,;-.67,-3.47,;.67,-2.69,;.67,-1.15,;-.67,-.38,;-.67,1.15,;-2,1.93,;-2,3.47,;-3.33,4.23,;-4.67,3.47,;-4.67,1.93,;-3.33,1.15,;-6,4.23,;-7.34,3.47,;-6,5.78,;.67,1.93,;.67,3.47,;2,1.15,;3.33,1.93,;3.33,3.47,;4.67,4.23,;6,3.47,;6,1.93,;7.34,1.15,;4.67,1.15,;2,-.38,;3.33,-1.15,)| InChI=1S/C25H22ClN3O5/c1-34-20-7-3-6-18-21(20)27-13-19-22(18)28(16-10-8-14(9-11-16)24(31)32)25(33)29(23(19)30)17-5-2-4-15(26)12-17/h2-7,12-14,16H,8-11H2,1H3,(H,31,32) VLSIAPYZDCCBPU-UHFFFAOYSA-N 135819 US8853226, 103::US9393245, 103::US10085990, Example 103::US10568888, Example 103 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 17.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135819&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 74931538 249493587 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548982 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)C(O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r,wU:16.21,(-4.67,-5.78,;-3.33,-5,;-3.33,-3.47,;-4.67,-2.69,;-4.67,-1.15,;-3.33,-.38,;-2,-1.15,;-2,-2.69,;-.67,-3.47,;.67,-2.69,;.67,-1.15,;-.67,-.38,;-.67,1.15,;-2,1.93,;-2,3.47,;-3.33,4.23,;-4.67,3.47,;-4.67,1.93,;-3.33,1.15,;-6,4.23,;-7.34,3.47,;-6,5.78,;.67,1.93,;.67,3.47,;2,1.15,;3.33,1.93,;3.33,3.47,;4.67,4.23,;6,3.47,;6,1.93,;7.34,1.15,;4.67,1.15,;2,-.38,;3.33,-1.15,)| InChI=1S/C25H22ClN3O5/c1-34-20-7-3-6-18-21(20)27-13-19-22(18)28(16-10-8-14(9-11-16)24(31)32)25(33)29(23(19)30)17-5-2-4-15(26)12-17/h2-7,12-14,16H,8-11H2,1H3,(H,31,32) VLSIAPYZDCCBPU-UHFFFAOYSA-N 135819 US8853226, 103::US9393245, 103::US10085990, Example 103::US10568888, Example 103 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 55.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135819&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 74931538 249493587 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548983 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3 QBTZSDNOQVLDBB-UHFFFAOYSA-N 135820 US8853226, 115::US9393245, 115::US10085990, Example 115::US9833457, 115::US10568888, Example 115 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 49.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135820&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 91618206 249493588 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548984 COc1cccc2c1ncc1c2n([C@@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3 QBTZSDNOQVLDBB-UHFFFAOYSA-N 135820 US8853226, 115::US9393245, 115::US10085990, Example 115::US9833457, 115::US10568888, Example 115 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 163 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135820&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 91618206 249493588 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548985 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3 QBTZSDNOQVLDBB-UHFFFAOYSA-N 135821 US8853226, 118::US9393245, 118::US10085990, Example 118::US9833457, 118::US10568888, Example 118 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 80.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135821&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 91618207 249493589 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548986 COc1cccc2c1ncc1c2n([C@H]2CCN(C2)S(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r| InChI=1S/C23H21ClN4O5S/c1-33-19-8-4-7-17-20(19)25-12-18-21(17)27(16-9-10-26(13-16)34(2,31)32)23(30)28(22(18)29)15-6-3-5-14(24)11-15/h3-8,11-12,16H,9-10,13H2,1-2H3 QBTZSDNOQVLDBB-UHFFFAOYSA-N 135821 US8853226, 118::US9393245, 118::US10085990, Example 118::US9833457, 118::US10568888, Example 118 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 206 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135821&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 91618207 249493589 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548987 CCS(=O)(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-3-36(33,34)28-12-10-17(11-13-28)29-23-19-8-5-9-21(35-2)22(19)27-15-20(23)24(31)30(25(29)32)18-7-4-6-16(26)14-18/h4-9,14-15,17H,3,10-13H2,1-2H3 IISWCMIDUMTUPJ-UHFFFAOYSA-N 135822 US8853226, 121::US9393245, 121::US10085990, Example 121::US9833457, 121::US10568888, Example 121 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 26.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135822&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 76762313 249493590 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548988 CCS(=O)(=O)N1CCC(CC1)n1c2c3cccc(OC)c3ncc2c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O5S/c1-3-36(33,34)28-12-10-17(11-13-28)29-23-19-8-5-9-21(35-2)22(19)27-15-20(23)24(31)30(25(29)32)18-7-4-6-16(26)14-18/h4-9,14-15,17H,3,10-13H2,1-2H3 IISWCMIDUMTUPJ-UHFFFAOYSA-N 135822 US8853226, 121::US9393245, 121::US10085990, Example 121::US9833457, 121::US10568888, Example 121 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 59.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135822&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 76762313 249493590 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548989 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)CS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O7S2/c1-37-21-8-4-7-19-22(21)27-14-20-23(19)29(25(32)30(24(20)31)18-6-3-5-16(26)13-18)17-9-11-28(12-10-17)39(35,36)15-38(2,33)34/h3-8,13-14,17H,9-12,15H2,1-2H3 SMPOHPYMVGJQOO-UHFFFAOYSA-N 135823 US8853226, 122::US9393245, 122::US10085990, Example 122::US9833457, 122::US10568888, Example 122 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 39.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135823&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 76762332 249493591 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548990 COc1cccc2c1ncc1c2n(C2CCN(CC2)S(=O)(=O)CS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O InChI=1S/C25H25ClN4O7S2/c1-37-21-8-4-7-19-22(21)27-14-20-23(19)29(25(32)30(24(20)31)18-6-3-5-16(26)13-18)17-9-11-28(12-10-17)39(35,36)15-38(2,33)34/h3-8,13-14,17H,9-12,15H2,1-2H3 SMPOHPYMVGJQOO-UHFFFAOYSA-N 135823 US8853226, 122::US9393245, 122::US10085990, Example 122::US9833457, 122::US10568888, Example 122 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 80.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135823 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135823&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 76762332 249493591 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7 548991 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)NS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r,wU:16.21,(-4,-5.01,;-2.67,-4.24,;-2.67,-2.7,;-4,-1.93,;-4,-.39,;-2.67,.38,;-1.33,-.39,;-1.33,-1.93,;,-2.7,;1.33,-1.93,;1.33,-.39,;,.38,;,1.92,;-1.33,2.69,;-1.33,4.23,;-2.67,5.01,;-4,4.23,;-4,2.69,;-2.67,1.92,;-5.33,5,;-6.67,4.23,;-8,5,;-7.44,2.9,;-5.9,2.9,;1.33,2.69,;1.33,4.23,;2.67,1.92,;4,2.69,;4,4.23,;5.33,5,;6.67,4.23,;6.67,2.69,;8,1.92,;5.33,1.92,;2.67,.38,;4,-.39,)| InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(17-11-9-16(10-12-17)28-36(2,33)34)25(32)30(24(20)31)18-6-3-5-15(26)13-18/h3-8,13-14,16-17,28H,9-12H2,1-2H3 QMGJUCFLYMBHRX-UHFFFAOYSA-N 135824 US8853226, 127::US9393245, 127::US10085990, Example 127::US9833457, 127::US10568888, Example 127 cAMP-specific 3',5'-cyclic phosphodiesterase 4B Human 25.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135824&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search 72279277 249493592 1 MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT 3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U 3',5'-cyclic-AMP phosphodiesterase 4B PDE4B_HUMAN Q07343 A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6 548992 COc1cccc2c1ncc1c2n(C2CC[C@@H](CC2)NS(C)(=O)=O)c(=O)n(-c2cccc(Cl)c2)c1=O |r,wU:16.21,(-4,-5.01,;-2.67,-4.24,;-2.67,-2.7,;-4,-1.93,;-4,-.39,;-2.67,.38,;-1.33,-.39,;-1.33,-1.93,;,-2.7,;1.33,-1.93,;1.33,-.39,;,.38,;,1.92,;-1.33,2.69,;-1.33,4.23,;-2.67,5.01,;-4,4.23,;-4,2.69,;-2.67,1.92,;-5.33,5,;-6.67,4.23,;-8,5,;-7.44,2.9,;-5.9,2.9,;1.33,2.69,;1.33,4.23,;2.67,1.92,;4,2.69,;4,4.23,;5.33,5,;6.67,4.23,;6.67,2.69,;8,1.92,;5.33,1.92,;2.67,.38,;4,-.39,)| InChI=1S/C25H25ClN4O5S/c1-35-21-8-4-7-19-22(21)27-14-20-23(19)29(17-11-9-16(10-12-17)28-36(2,33)34)25(32)30(24(20)31)18-6-3-5-15(26)13-18/h3-8,13-14,16-17,28H,9-12H2,1-2H3 QMGJUCFLYMBHRX-UHFFFAOYSA-N 135824 US8853226, 127::US9393245, 127::US10085990, Example 127::US9833457, 127::US10568888, Example 127 cAMP-specific 3',5'-cyclic phosphodiesterase 4D Human 73.0 25.00 C US Patent 10.7270/Q2RV0QRM aid1795749 US10085990 Mjalli, AM; Gaddam, B; Polisetti, DR; Kostura, MJ; Guzel, M 10/2/2018 1/17/2019 Vtv Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=135824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=135824&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search 72279277 249493592 1 MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT 7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J 3',5'-cyclic-AMP phosphodiesterase 4D PDE4D_HUMAN Q08499 O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7